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In Brief
Sreedharan et al. use a novel approach to
study neurodegeneration in the
Drosophila leg, finding that TDP-43
causes age-dependent dying-back
degeneration of motor neurons. In a
mosaic genetic screen, loss of GSK3, hat-
trick, or xmas-2 is shown to suppress
TDP-43 toxicity. TDP-43-mediated axon
degeneration is distinct from Wallerian
degeneration.
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The RNA-processing protein TDP-43 is central to the
pathogenesis of amyotrophic lateral sclerosis (ALS),
themost commonadult-onsetmotor neuron (MN) dis-
ease [1–4]. TDP-43 is conserved in Drosophila, where
it has been the topic of considerable study, but how
TDP-43 mutations lead to age-dependent neurode-
generation is unclear and most approaches have not
directly examined changes in MN morphology with
age [5]. We used a mosaic approach to study age-
dependent MN loss in the adult fly leg where it is
possible to resolve single motor axons, NMJs and
active zones, and perform rapid forward genetic
screens. We show that expression of TDP-43Q331K
caused dying-back of NMJs and axons, which could
not be suppressed by mutations that block Wallerian
degeneration. We report the identification of three
genes that suppress TDP-43 toxicity, including
shaggy/GSK3, a known modifier of neurodegenera-
tion [6]. The two additional novel suppressors, hat-
trick and xmas-2, function in chromatin modeling
and RNA export, two processes recently implicated
in human ALS [7, 8]. Loss of shaggy/GSK3, hat-trick,
or xmas-2 does not suppressWallerian degeneration,
arguingTDP-43Q331K-induced andWalleriandegener-
ation are genetically distinct processes. In addition
to delineating genetic factors that modify TDP-43
toxicity, these results establish the Drosophila adult
leg as a valuable new tool for the in vivo study of adult
MN phenotypes.
RESULTS AND DISCUSSION
Characterizing MARCM Clones in Motor Neurons in the
Adult Drosophila Leg
Existing approaches to studying neurodegeneration inDrosophila
are limited by a reliance on phenotypic changes in external eye
morphology [9], non-neural structures [10], or changes in lifespan
after widespread neural expression of disease genes [11]. The
most commonly used synaptic preparation, the larval NMJ, can
only be studied for 3 to 4 days of larval life, precluding its use as2130 Current Biology 25, 2130–2136, August 17, 2015 ª2015 Elseviea model of age-dependent changes in motor neurons (MNs).
Furthermore, the remarkable growth of larval NMJs and axons
may confound the interpretation of degenerative phenotypes
[12]. We sought to develop a Drosophila amyotrophic lateral
sclerosis (ALS) model that allowed for the study of age-depen-
dent changes in fully differentiated adult MNs with single-cell
resolution.
We expressed membrane-tethered GFP (UAS-mCD8::GFP)
using OK371-Gal4 to label glutamatergic neurons in adult fly
legs. We then used MARCM [13], which through its sparse label-
ing facilitated detailed examination of subcompartments of indi-
vidual motor and sensory neurons (Figures 1A and 1B) [15]. To
induce MARCM leg clones, we tested a number of genetically
encoded flippase (FLP) sources we recently developed [16].
We found that, by driving FLPwith the promoter from the proneu-
ral gene asense (ase-FLP), we could efficiently induce leg MN
clones in 90% of animals.
mCD8-GFP was present throughout NMJs in MARCM clones
but also formed bright punctae reminiscent of presynaptic active
zones [17]. Indeed, these punctae colocalized with the active
zone protein Bruchpilot (Brp) and were apposed to post-synap-
tic glutamate receptor GluRIIA subunits (Figures 1C and 1D).
Some NMJs were negative for GluRIIA (Figure 1D, middle panel),
possibly because they express GluRIIB, which is interchange-
able with GluRIIA in Drosophila [14]. Brp was also closely
apposed to the post-synaptic protein DLG (Figure S1A). These
results highlight the utility of MARCM clonal analysis with genet-
ically encoded FLP sources and mCD8-GFP labeling to study
adult MN development and aging with exceptionally high cellular
resolution.
TDP-43 Causes Progressive Degeneration of Adult
Motor Axons and NMJs
Both loss and gain of function of TDP-43 are thought to
contribute to ALS [3, 5, 18]. We therefore investigated the ef-
fects of knockdown of TBPH, the fly ortholog of TDP-43, and
overexpression of TBPH or TDP-43 [19–21]. Typically, such
modulation of TBPH/TDP-43 in MNs causes early lethality
[19–21]. However, our MARCM background facilitated spatial
restriction of expression of toxic transgenes to clones, which
allowed for animal survival and the opportunity to examine
age-dependent changes in MN morphology. TBPH-RNAi did
not cause observable degeneration of MARCM MN clones,
despite its ability to efficiently knock down TBPH (Figure S1D).
This is consistent with a previous study, which found that lossr Ltd All rights reserved
Figure 1. MARCM Clones of Leg Motor Neurons Can Be Induced Using Asense-FLP and Demonstrate Progressive NMJ and Axon Degen-
eration with Overexpression of TDP-43Q331K
(A) Labeling of all glutamatergic neurons in a middle leg. Arrowheads indicate sensory cell bodies. Red and yellow boxes indicate the regions used for imaging
axons and NMJs, respectively, for all subsequent quantification.
(B) Low power image of a single motor neuron clone. Magnification of a nerve terminal (inset) highlights mCD8::GFP punctae.
(C) Colocalization of mCD8::GFP with mCherry-tagged active zone protein Bruchpilot [14].
(D) 3D projection view of a leg NMJ demonstrates close apposition of post-synaptic GluRIIA-mRFP and pre-synaptic mCD8::GFP.
(E) Time course of motor axon and NMJ degeneration caused by TDP-43Q331K.
(F) Quantification of mild to moderate axon degeneration, comparing leg motor with wing sensory neurons. Genotypes used were (A) w; OK371-Gal4, UAS-
mCD8::GFP; UAS-mCD8::GFP, (B) w, tub-Gal80, FRT19A/FRT19A; OK371-Gal4, UAS-mCD8::GFP; UAS-mCD8::GFP, ase-FLP, (C) w, tub-Gal80, FRT19A/
FRT19A; OK371-Gal4, UAS-mCD8::GFP, UAS-BrpmCh; UAS-mCD8::GFP, ase-FLP, (D) w, tub-Gal80, FRT19A/FRT19A; OK371-Gal4, UAS-mCD8::GFP; UAS-
mCD8::GFP, ase-FLP/dGluRIIA-mRFP, and (E)w, tub-Gal80, FRT19A/FRT19A;OK371-Gal4,UAS-mCD8::GFP;UAS-mCD8::GFP,UAS-TDP-43Q331K, ase-FLP.
The scale bars represent 10 mm. See also Figure S1.of TBPH does not cause obvious changes in NMJ structure but
results in significant electrophysiological effects that impair
neurotransmission [19]. By contrast, overexpression of TBPH
or TDP-43 caused clear motor axon and NMJ degeneration
(Figures S1B and S1C). The observed toxicity requires RNA-
binding activity as expression of TDP-43FFLL [21], which lacks
RNA binding activity, was non-toxic (Figure S1E). We also ex-
pressed mutant forms of other ALS-linked proteins (FUSR521G,
SOD1A4V, and SOD1G85R) in MARCM clones but found that
these did not cause severe phenotypes as observed with
TDP-43 (data not shown).
The effects of TDP-43Q331K expression were far more severe
than other manipulations. By 7 days post-eclosion (7 dpe),
TDP-43Q331K expression caused degeneration in over 50% of
MNs (Figure 1E). Axons developed transverse striations and pro-
gressively lost structural integrity, and NMJs exhibited reduced
active zone density (Figures 1E and 1F). Interestingly, TDP-43
expression remained predominantly nuclear (Figure S1F) and
apoptosis was not observed inMN cell bodies (Figure S1G), indi-
cating that neural processes were degenerating before nuclear
loss in a ‘‘dying-back’’ manner akin to that seen in ALS [22].
Sensory neurons were less severely affected by expression ofCurrent Biology 25, 2130–TDP-43Q331K (Figure S1H). These data argue for some level
of MN specificity in the effects of TDP-43Q331K and indicate the
Drosophila leg should serve as an excellent tool to study
the cellular and molecular basis of TDP-43-induced MN
degeneration.
Blocking Wallerian Degeneration Genes Does Not
Ameliorate TDP-43Q331K Toxicity
Wallerian degeneration (WD), the programmed destruction of
distal severed axons that follows axotomy, is conserved in flies
and mammals [23] and can be potently delayed by overexpres-
sion of WldS (a chimeric protein incorporating the NAD-synthe-
sizing enzyme NMNAT1) [24, 25] or by null mutations in dSarm/
Sarm1 [26] or highwire/Phr1 [27, 28]. Intriguingly, axon degener-
ation in neurodegenerative diseases may be Wallerian-like as
WldS expression can ameliorate disease phenotypes in mouse
models of motor neuropathy [29], Parkinson’s disease [30],
and glaucoma [31], though little effect has been seen in SOD1
mouse models of ALS [32, 33]. Whether WldS, dSarm/Sarm1,
or highwire/Phr1 modify phenotypes in TDP-43 models of neu-
rodegeneration had not been explored. We therefore co-ex-
pressed WldS or eliminated dSarm or Highwire function in leg2136, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2131
Figure 2. Loss of sgg Suppresses TDP-43
Toxicity
(A) Motor axon and NMJ morphology of, from left
to right, GFP control, TDP-43 control, TDP-43 in
line 11 background, and GFP in line 11 back-
ground. The scale bar represents 5 mm.
(B) Quantification of axon degeneration and ag-
gregation of GFP at NMJs in sgg mutants and
rescue crosses with a duplication covering sgg
(stock DC048) and UAS-sgg.
(C) Cartoon of the sgg gene with the position of the
premature stop mutation found in line 11 (L245*).
The position of the previously uncharacterized P-
element insertion (line sggG0183) in the 50 UTR of an
alternative transcript is shown for comparison.
(D) Western blotting of third-instar larval brains
from homozygous sgg mutants and quantification
of TDP-43 band intensity. Values are the average
of three biological replicates and given as mean ±
SEM. ns, non-significant.
See also Figures S2 and S3.MARCM clones expressing TDP-43Q331K. We observed no
obvious amelioration of MN degeneration (Figures S1I and
S1J), suggesting that molecules that drive WD are not the pri-
mary effectors of axon loss in our TDP-43 MN model.
A Forward Genetic Screen Identifies Three Suppressors
of TDP-43 Toxicity
We performed an EMS-based forward genetic MARCM screen
of the X chromosome for suppressors of TDP43Q331K-induced
MN degeneration (Figure S2). Of 3,189 mutant lines screened,
five lines significantly suppressed TDP-43Q331K toxicity at 7
dpe. Each of these mutants also suppressed MN degeneration
induced by overexpression of TDP-43WT (Figure S3H). The
axon-rescuing phenotypes of all lines co-segregated with
third-instar larval lethality after extensive out-crossing.We there-
fore mapped lethality to define candidate regions using X to Y
chromosome duplication lines [34], performed complementation2132 Current Biology 25, 2130–2136, August 17, 2015 ª2015 Elsevier Ltd All rights reservedcrosses among lines, and used whole-
genome sequencing to molecularly iden-
tify three distinct suppressors of TDP-
43Q331K toxicity.
sgg/GSK3 Is Required for
TDP-43-Induced MN Degeneration
Line 11 was the weakest suppressor of
TDP-43 toxicity (Figures 2A, 2B, S3H,
and S3I). We mapped lethality of line 11
to cytological region 3A8-3B2, which
contains shaggy (sgg), and sequencing
identified a premature stop mutation in
sgg that abolished sgg expression (Fig-
ures 2C and 2D). We therefore renamed
line 11 sggJ11. Interestingly, independent
of TDP-43 expression, we observed that
sggJ11 NMJs displayed altered mor-
phology, with variability in the size and
shape of active zones and enlarged bou-
tons. Consistent with our identification ofthis gene as sgg, similar changes in NMJ growth have been
described in mutants affecting the sgg locus [35].
To further confirm that loss of sgg suppresses TDP-43 toxicity,
we obtained two additional loss-of-function alleles of sgg,
sggG0183 and sgg1 [1, 36], which failed to complement sggJ11.
MARCM clones of sggG0183 and sgg1 [1] suppressed TDP-43
toxicity and phenocopied sggJ11 in defects in NMJ morphology.
We additionally rescued the phenotype of TDP-43 toxicity in
sggJ11 clones with a genomic duplication and MARCM clone-
specific cDNA expression (Figure 2B). Interestingly, immuno-
blotting of homozygous sggJ11 larval brain extracts showed
that loss of sgg did not affect TDP-43 levels (Figure 2D). These
data collectively indicate that loss of sgg suppresses TDP-43
toxicity without reducing TDP-43 expression.
sgg/GSK3 has been widely implicated in neurodegenera-
tion. Our isolation of sggJ11 as a suppressor of TDP-43 toxicity
argues strongly that the adult fly leg MN system can provide
physiologically relevant insights into themolecular details of ALS
pathogenesis. A mechanistic link between TDP-43 and GSK3 is
supported by observations that TDP-43 activates GSK3 and that
GSK3 inhibition reduces TDP-43 aggregation [37–40]. Interest-
ingly, the GSK3 inhibitor kenpaullone can suppress degenera-
tion of human-stem-cell-derived MNs in vitro [39], supporting a
pro-degenerative role for GSK3. Our novel observation that
loss of sgg suppresses TDP-43-mediated MN degeneration
in vivo further supports the notion that modulation of GSK3-
linked pathways may have therapeutic potential in ALS.
hat-trick and xmas-2 Are Required for TDP-43 Toxicity
Lines 39, 47, and 71 demonstrated comparably strong suppres-
sion of TDP-43Q331K toxicity (Figures 3A–3C) and defined a single
lethal complementation group in cytological region 17D6-17F2.
Each line contained a unique mutation in the previously unchar-
acterized gene CG34422 (Figure 3D). Lines 47 and 71 harbor
premature stop codons, whereas line 39 contains a donor splice
site mutation, impairing splicing of intron 2 (Figure 3E) and likely
leading to read-through of the transcript to an intronic premature
stop codon. These are all predicted loss-of-function mutations
in CG34422, and we were able to rescue the phenotype of
TDP-43 toxicity in these three lines using a duplication covering
CG34422. We therefore conclude that loss of CG34422 sup-
presses TDP-43 toxicity.
CG34422 is predicted to have two main transcripts, both
of which have a chromatin organization modifier (CHROMO)
domain. The longer isoform also has an AT-rich interacting
domain (ARID) and an RBB1NT (NUC162) domain, which is
found in DNA-binding proteins of the retinoblastoma-binding
protein 1 family. Given the putative role of CG34422 in hetero-
chromatin association and its influence on TDP-43 toxicity, we
renamed the gene hat-trick.
The mammalian orthologs of hat-trick, ARID4A and ARID4B,
interact in a complex with the tumor suppressor retinoblastoma
protein (RB) [41]. To investigate a potential role for the fly ortho-
log of RB (Rbf) in suppressing TDP-43 toxicity, we asked
whether homozygous Rbf mutant clones could suppress TDP-
43 toxicity. However, loss of Rbf did not suppress TDP-43
toxicity (Figure S3E), suggesting that the suppression afforded
by loss of hat-trick is independent of previously characterized
Rbf interactions.
Immunoblotting of homozygous hat-trick71 larval brain ex-
tracts (Figures 3I, S3A, and S3B), and analysis of hat-trick71
MARCM clones in MNs (Figures 3H and S3C) revealed that
loss of hat-trick was associated with a decrease in TDP-43 pro-
tein expression. The decrease in TDP-43 protein appears to be
post-transcriptional because we observe no significant change
in TDP-43 mRNA transcript levels (Figure 3J). Decreases in
TDP-43 could be causative for the suppressive phenotype,
perhaps as a result of reduced translation of TDP-43 mRNA or
an increase in the cellular ability to turn over TDP-43 protein.
Alternatively, it is possible that the modest reduction in TDP-43
expression is not responsible for the suppression in toxicity
seen with hat-trick mutants. Given the putative role of hat-trick
in chromatin modeling, it is tempting to speculate that loss of
hat-trick may prevent cell-cycle re-entry, a mechanism that
has been linked to ALS pathogenesis [42] and, specifically,
TDP-43 toxicity [38, 43]. Indeed, mutations in genes encodingCurrent Biology 25, 2130–other chromatin regulators are over-represented in ALS [7].
Furthermore, TDP-43 overexpression in a mouse model of ALS
was associated with a profound increase in the expression of
chromatin assembly genes [44].
Among all isolated suppressors, line 45 demonstrated the
strongest suppression of TDP-43 toxicity (Figures 3A–3C, S3H,
and S3I). Lethality was mapped to cytological region 15E5-
15F1, which harbored two genetic variants relative to control se-
quences. The first is a missense variant in the xmas-1 gene
(C2079T) predicted to cause an A693V substitution (Figures
S3F and S3G). However, several species have valine as wild-
type at this position, suggesting that the C2079T change is not
pathogenic. The second variant introduces a premature stop
codon in the xmas-2 gene, abolishing xmas-2 protein expression
(Figures 3F and 3G). We found that another lethal hypomorphic
xmas-2 allele, xmas-2f04114, failed to complement the lethality
of xmas-245, and homozygous xmas-2f04114 clones also sup-
pressed TDP-43 toxicity (Figure 3C). We conclude that the
missense mutation in xmas-1 is unrelated to the observed MN
phenotypes, rather it is loss of xmas-2 that potently suppresses
TDP-43 toxicity.
As xmas-2 is involved in transcription and RNA export, we
hypothesized that xmas-245 may suppress TDP-43 toxicity by
influencing TDP-43 expression. Indeed, immunoblotting of
homozygousmutant xmas-245 larval brain extracts and immuno-
histochemistry of adult MARCM clones demonstrated a 60%–
70% decrease in TDP-43 expression (Figures 3H, 3I, S3A, and
S3C). However, no significant changes in TDP-43, GFP, or
GAL4 mRNA transcripts were observed (Figure 3J). These data
argue that xmas-245 affects TDP-43 levels post-transcriptionally
but does not reduce transgene expression by the OK371-Gal4
driver.
Post-transcriptional suppression of TDP-43 expression in
xmas-2 mutant MNs would be consistent with a loss of the
RNA-export function of xmas-2, which could block nuclear
export of TDP-43 transcripts and reduce translation. Interest-
ingly, mutations in the RNA export gene hGle1 cause fetal MN
disease and have recently been associated with ALS [8],
whereas loss of several components of the RNA transcription
and export complex (TREX) suppress TDP-43 toxicity in yeast
[45]. We therefore sought to determine whether other compo-
nents of the RNA export machinery are involved in mediating
TDP-43 toxicity in Drosophila. The mammalian ortholog of
xmas-2, germinal-center-associated nuclear protein (GANP),
functions in a complex with NXF1 to facilitate the nuclear export
of mRNAs [46]. To investigate a possible role for NXF1 in sup-
pressing TDP-43 toxicity, we generated clones lacking the fly or-
tholog of NXF1, Sbr. However, sbr [12] null mutant clones failed
to suppress TDP-43 toxicity (Figure S3E). These data suggest
that xmas-2 mediates TDP-43 toxicity independently of Sbr/
NXF1 or that loss of xmas-2 may suppress toxicity through
mechanisms other than by inhibiting RNA export.
Mutants of sgg/GSK3, hat-trick, and xmas-2 Do Not
Suppress WD
Previous studies have reported that loss of sgg/GSK3 can
modestly suppress axotomy-induced WD [47], suggesting that
suppressors of neurodegeneration can influence WD. To test
this hypothesis, we severed axons in the adult wing [16] to2136, August 17, 2015 ª2015 Elsevier Ltd All rights reserved 2133
Figure 3. Loss-of-Function Mutations in hat-trick and xmas-2 Suppress TDP-43Q331K-Mediated Motor Neuron Degeneration
(A) Motor axon and NMJ morphology of, from left to right, GFP control, TDP-43 control, TDP-43 in line 71 background, and TDP-43 in line 45 background. The
scale bar represents 5 mm.
(B) Quantification of active zones in GFP and TDP-43 background. ****p < 0.0001.
(C) Quantification of axon and NMJ degeneration in hat-trick and xmas-2 mutants and in rescue experiments with duplication stocks DC353 and DC325.
(D) The hat-trick gene is shown with newly isolated alleles: red arrows indicate premature stop mutations in line 71 (L982*) and 47 (Q2145*) and green arrow
indicates the intronic donor splice site mutation in line 39 (IVS2+2T > A).
(E) Agarose gel electrophoresis of PCR products from cDNA extracted from third-instar larval brains of homozygous hat-trick mutant lines. Location of PCR
primers is indicated in (D).
(F) The xmas-2 gene is shown with the line 45 premature stop mutation (Q241*, red arrow) and the PBac insertion (blue arrow).
(G) Western blotting for xmas-2 in third-instar larval brains from homozygous xmas-2 mutants.
(H) Immunohistochemistry for TDP-43 of thoracic ganglia motor neuron cell bodies at 7 dpe. The scale bar represents 10 mm.
(I) Western blotting for TDP-43 and GFP of third-instar larval brains. Note that the molecular weight of GFP is at 50 kDa as it is bound to mCD8 protein.
(J) Third-instar larval brain qRT-PCR. Homozygous animals of each genotype were used. Expression normalized to that of control brains. Values are the average
of three biological replicates and given as mean ± SEM.
See also Figures S2 and S3.
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determine whether sggJ11, hat-trick71, and xmas-245 could sup-
pressWD. However, we found that none of these mutants signif-
icantly delayed WD (Figures S3J and S3K). These data, together
with our observation that neither overexpression ofWldS nor loss
of dSarm and Highwire modify TDP-43Q331K toxicity in leg MNs,
argue strongly that the signaling pathways regulating WD- and
TDP-43Q331K-induced toxicity are genetically distinct.
In conclusion, our use of MARCM analysis with genetically en-
coded FLP sources in adult leg MNs has allowed us to explore
TDP-43 toxicity in Drosophila with unprecedented speed and
cellular resolution. This approach represents an important step
forward for the field. First, it facilitates rapid analysis of the fine
morphology of adult MN axons and synaptic connections in vivo.
Second, it permits studies of changes in MN cell biology in
adult animals as they age in backgrounds carrying lethal vari-
ants, such as TDP-43Q331K, or any disease-linked gene. Finally,
and perhaps most importantly, it allows for the use of unbiased
forward genetic screens to rapidly isolate modifiers of MN pa-
thology, such as the three suppressors of TDP-43-induced
toxicity we report here. Because we have screened only 20%
of the fly genome, a wealth of additional suppressors of TDP-
43 toxicity await further discovery.
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